PLDT Inc. has received a notice from the New York Stock Exchange (NYSE) regarding the late filing of its annual reports on Form 20-F. This notice, filed on November 12, 2026, underlines the company's ongoing challenges in meeting regulatory compliance deadlines. The situation is significant as it may affect PLDT's standing with investors and could lead to increased scrutiny from market regulators.
PLDT Inc., a prominent player in the telecommunications sector, operates under the Standard Industrial Classification (SIC) code 4813, which pertains to Telephone Communications (No Radiotelephone). The company trades on the NYSE under the ticker symbol PHI and on the OTC market under PHTCF. Recently, PLDT has been active in filing various reports, with multiple submissions made on November 12, 2026, alone.
According to the SEC filing (accession number 0001193125-26-456722), the company submitted a press release titled "PLDT receives NYSE Notice regarding Late Filing of Annual Reports on Form 20-F." This press release was also shared with the Philippine Stock Exchange and the Philippine Securities and Exchange Commission, indicating a commitment to transparency. The filing emphasized that the notice was submitted pursuant to Section 802.01E of the NYSE Listed Company Manual.
The late filing may have implications for PLDT's investors and stakeholders, as it raises questions about the company's internal processes and adherence to regulatory requirements. Investors often view timely filings as a sign of a company's operational health and reliability. Additionally, this situation may prompt competitors within the telecommunications industry to reevaluate their own compliance practices to avoid similar issues.
As for what happens next, the filing does not specify any immediate actions or responses from PLDT regarding the NYSE notice. However, the company is likely to prioritize resolving the compliance issue to maintain its reputation and investor trust.
Read Next
Jianzhi Education to Hold Extraordinary General Meeting
Beamr Imaging forecasts 50% revenue growth for 2026
Can-Fite BioPharma Reports Breakthrough in Kidney Disease Study
OKYO Pharma to Attend 2026 Jefferies Global Healthcare Conference
A2Z Cust2Mate Solutions Corp. Reports Q3 Financial Results
PLDT Inc. reports third-quarter results for 2026










